Kliniken und Institute


Institut für Humangenetik


Wollnik

Leitung

Direktor des Instituts
Prof. Dr. Bernd Wollnik

Sekretariat

Telefon: +49 (0) 551 39-75 89
Fax: +49 (0) 551 39-93 03
E-Mail: petra.albers@med.uni-goettingen.de

Anschrift

Heinrich-Düker-Weg 12
37073 Göttingen

Briefpostadresse

37099 Göttingen

Homepage

URL / Homepage www.humangenetik-umg.de

Downloads

PDF Publikationen 2015 2014 2013 2012 2011

PDF Qualitätsbericht 2013 2010 2008

Ausgewählte Publikationen
  • Harley ME, Murina O, Leitch A, Higgs MR, Bicknell LS, Yigit G, Blackford AN, Zlatanou A, Mackenzie KJ, Reddy K, Halachev M, McGlasson S, Reijns MAM, Fluteau A, Martin CA, Sabbioneda S, Elcioglu NH, Altmüller J, Thiele H, Greenhalgh L, Chessa L, Maghnie M, Salim M, Bober MB, Nürnberg P, Jackson SP, Hurles ME, Wollnik B, Stewart GS, Jackson AP (2016) TRAIP promotes DNA damage response during genome replication and is mutated in primordial dwarfism. NAT GENET 48(1):36-43.
  • Hatzold J, Beleggia F, Herzig H, Altmüller J, Nürnberg P, Bloch W, Wollnik B, Hammerschmidt M (2016) Tumor suppression in basal keratinocytes via dual non-cell-autonomous functions of a Na,K-ATPase beta subunit. ELIFE 16,5 doi: 10.7554/eLife.14277.
  • Dräger J, Simon-Keller K, Pukrop T, Klemm F, Wilting J, Sticht C, Dittmann K, Schulz M, Leuschner I, Marx A, Hahn H (2017) LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma. ONCOTARGET 8(2):3259-3273.
  • Gehrig J, Kaulfuß S, Jarry H, Bremmer F, Stettner M, Burfeind P, Thelen P (2017) Prospects of estrogen receptor β activation in the treatment of castration-resistant prostate cancer. ONCOTARGET 8(21):34971-34979.
  • Gordon CT, Xue S, Yigit G, Filali H, Chen K, Rosin N, Yoshiura KI, Oufadem M, Beck TJ, McGowan R, Magee AC, Altmüller J, Dion C, Thiele H, Gurzau AD, Nürnberg P, Meschede D, Mühlbauer W, Okamoto N, Varghese V, Irving R, Sigaudy S, Williams D, Ahmed SF, Bonnard C, Kong MK, Ratbi I, Fejjal N, Fikri M, Elalaoui SC, Reigstad H, Bole-Feysot C, Nitschké P, Ragge N, Lévy N, Tunçbilek G, Teo AS, Cunningham ML, Sefiani A, Kayserili H, Murphy JM, Chatdokmaiprai C, Hillmer AM, Wattanasirichaigoon D, Lyonnet S, Magdinier F, Javed A, Blewitt ME, Amiel J, Wollnik B, Reversade B (2017) De novo mutations in SMCHD1 cause Bosma arhinia microphthalmia syndrome and abrogate nasal development. NAT GENET 49(2):249-255.

Suchworte: Entwicklungsgenetik, genomische Instabilität, molekulare Pathogenese, MutationMining-Team, Next Generation Sequencing, Panel-Diagnostik, Progerie, seltene Erkrankungen, Tumorgenetik